DAFTAR PUSTAKA

Maina G, Mauri M, Rossi A. (2016) Anxiety and depression. Journal of

Psychopathology. 22: 236-250.

Klein MO, Battagelllo DS, Cardos AR, Hauser DN, Bittencourt JC, Correa RG.
(2018). Dopamine: functions, signaling, and association with neurological
disease. Cellular and molecular neurobiology. November 2018.

Kehoe WA.. (2017). Generalized anxiety disorder. ACSAP 2017 Book 2 Neurologic/
Psychiatric Care.

Durjadin K, Sgambato V. (2020). Neuropsychiatric disorders in Parkinson’s disease:

what do we know about the role of dopaminergic and non-dopaminergic
systems? Frontiers in Neuroscience. 14:25.

Hawke PC, Brown B, Hammon S. (2017). Anxiety and its features in Parkinson’s
disease. SM J Neuro Neurosci; 3(1): 1008.

American Phsychological Association, 2020. https://www.apa.org/topics/anxiety/

Adams – Carr, K.L., Bestwick, J.P., Shribman, S., Lees, A.J., Schrag, A., Noyce,
A.J., 2015. Constipation preceding Parkinson’s Disease: a systemati review
and meta –analysis. J Neurol Neurosurg Psychiatri, p 1-7.

Ahmad B.2015. Gejala non motorik penyakirt Parkinson. In Penyakit Parkinson dan
Gangguan Gerak Lainnya.Buku panduan dan tatalaksana. Kelompok studi movement
disorders. Perdossi.pp 33-64
Bartels, A. and Leenders, K. (2009). Parkinson's disease: The syndrome, the
pathogenesis and pathophysiology. Cortex, 45(8), pp.915-921.

Bordelon, Y. and Keener, A. (2016). Parkinsonism. Seminars in Neurology, 36(04),

pp.330-334.
De Maagd, G., Philip A., 2015. Parkinson’s disease and its management part 1:
Disease entity, rist factors, pathophysiology, clinical presentation, and
diagnosis. P & t, vol 40 No. 8, p. 504 – 10.

Dewanto G. Manajemen gejala motoric dan non-motorik pada penyakit Parkinson.

Neurona Vol 29 No. 3 April 2012: 15-30.

Esmail, S. (2018) The diagnosis and managemenet of Parkinson’s disease. Sch J Appl
Sci Res, 1(9): 13-19.

Factor A, Weiner J. 2008. Parkinson’s disease: Diagnosis and clinical management.

Second edition. Cardinal feature of early Parkinson’s disease;47-49.

Factor S, Steenland, Higgins D, et al. 2011. Postural instability/gait disturbance in

Parkinson’s disease has distinct subtypes: an exploratory analysis. Journal
Neurology Neurosurgery Psychiatry;564-568.

Fahn S, Jancovic J. 2007. Parkinsonisme: Clinical Feature and Differential Diagnosis. In

Gao C, Smith S, Lones M, et al. 2018. Objective assessment of bradykinesia in

Parkinson’s disease using evolutionary algorithms: clinical validation.
Translational Neurodegeneration 7:18.

Grimes, D., Fitzpatrick, M., Gordon, J., Miyasaki, J., Fon, E., Schlossmacher, M.,
Suchowersky, O., Rajput, A., Lafontaine, A., Mestre, T., Appel-Cresswell, S.,
Kalia, S., Schoffer, K., Zurowski, M., Postuma, R., Udow, S., Fox, S.,
Barbeau, P. and Hutton, B. (2019). Canadian guideline for Parkinson
disease. Canadian Medical Association Journal, 191(36), pp.E989-E1004.

Hauser RA. 2012. Parkinson disease clinical presentation. Medscape reference ; 1-13.

Kelompok Studi Movement Disorder PERDOSSI. 2013 Buku Panduan Penyakit

Parkinson dan Gangguan Gerak Lainnya, Desantara Utama.
Kouli A, Torsney KM, Kuan WL. Parkinson’s Disease: Etiology, Neuropathology,
and Pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson’s Disease:
Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon
Publications; 2018 Dec 21. Chapter 1. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK536722/ 

Kurniawan, M., Suharjanti, I. and Pinzon, R. ed., (2016). Panduan Praktik Klinis

Neurologi. PERDOSSI, pp.218 - 236.

Lin, C., Lin, J., Liu, Y., Chang, C., Wu, R., 2014. Risk of Parkinson’s disease
following severe constipation: A nationwide population – based cohort study.
Parkinsonism and related disorers, p.1 – 5.

Mark, M. H., 2010. Parkinson’s Disease Handbook: A Guide for Patients and Their
Families. New Jersey: American Parkinson Disease Association, Inc.

Marsili, L., Rizzo, G. and Colosimo, C. (2018). Diagnostic Criteria for Parkinson’s
Disease: From James Parkinson to the Concept of Prodromal
Disease. Frontiers in Neurology, 9.

Massano J, Bhatia KP. Clinical approach to Parkinson’s disease: features, diagnosis,

and principles of management. Cold Spring Harbor perpectives in medicine.
2012 (6): 10-15.

Muzerengu S, Contrafatto D, Chaudhuri K. 2007. Non-motor symptoms:

Identification and management. Parkinsonism and Related Disorders 13 :
450–456.

Noyce, A.J., Bestwick, J. P.., Silveira – Moriyama, L., Hawkes, C.H., Giovannoni,
G., Lees, A.J., Schrag, A., 2012. Meta- analysis of earaly nonmotor features
and risk factors for Parkinson Disease. American neurological association
neurol, Vol. 72 No. 6, p. 893 – 901.
Oktariza, Y., Amalia, L., Sobaryati, S. and Kurniawati, M. (2019). Evaluasi Kualitas
Hidup Pasien Parkinson Berdasarkan Terapi Berbasis Levodopa. Indonesian
Journal of Clinical Pharmacy, 8(4), p.246.

Schapira A, Chaudhuri K, Jenner P. 2017. Non-motor features of Parkinson disease.

Neuroscience, vol.18;435-450.

Setyono J, Noviani E, Gunarto U. Hubungan antara merokok dengan penyakit

Parkinson di RSUD Prof. DR. Margono Soekarjo Purwokerto. Mandala
Health. 2010; 4 (2): 81 – 6.

Syamsudin, T., 2013. Penyakit Parkinson. Dalam: Buku Panduan Tatalaksana

Penyakit Parkinson dan Gangguan Gerak Lainnya. Kelompok Studi
Movement Disorder PERDOSSI.

Ton, T., Heckbert, S., Longstreth, W., Rossing, M., Kukull, W., Franklin, G.,
Swanson, P., Smith-Weller, T. and Checkoway, H. (2007). Calcium channel
blockers and β-blockers in relation to Parkinson's disease. Parkinsonism &
Related Disorders, 13(3), pp.165-169.

Tysnes OB & Storstein A. (2017). Epidemiology of Parkinson’s disease. Journal of

Neural Transmission, 124(8), 901–905.